8591AGT-HC168Open (affiliates only)Phase I Study to Evaluate the Safety of Genetically Modified, Autologous T
Cells in Participants with HIV that is Well-Controlled on Antiretroviral
TherapyNCT04561258IndustryAdultTreatmentOtherKumar, PrincyGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterGUMC Medicine Infectious Disease2021R3.1 Build 22 <a href="https://advarra.com" target="_blank">© 2024 Advarra, Inc.</a>